DexCom introduced the G6 in 2018, and since then, CGMs have become the standard of care for patients with diabetes. The company is actively working on its G7 version, which is in clinical trials.

Dexcom, Inc., a leader in continuous glucose monitoring, announced today that the company has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up.